iBio
IBIO
#10074
Rank
HK$0.21 B
Marketcap
HK$9.34
Share price
-6.25%
Change (1 day)
-53.65%
Change (1 year)

Market capitalization of iBio (IBIO)

Market cap: HK$0.21 Billion

As of December 2025 iBio has a market cap of HK$0.21 Billion. This makes iBio the world's 10074th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of iBio from 2008 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$0.21 B20.71%
2024HK$0.17 B711.19%
2023HK$21.45 M-31.37%
2022HK$31.25 M-96.65%
2021HK$0.93 B-45.87%
2020HK$1.72 B1528.96%
2019HK$0.10 B-4.78%
2018HK$0.11 B-30.35%
2017HK$0.15 B-41.54%
2016HK$0.27 B-18.67%
2015HK$0.33 B-12.24%
2014HK$0.38 B128.46%
2013HK$0.16 B-27.08%
2012HK$0.22 B9.97%
2011HK$0.20 B-73.71%
2010HK$0.79 B302.5%
2009HK$0.19 B936.59%
2008HK$19.03 M

End of Day market cap according to different sources

On Dec 5th, 2025 the market cap of iBio was reported to be:

HK$0.21 Billion
by Nasdaq info icon info icon
HK$0.21 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Genocea Biosciences
GNCA
HK$0.04 M-99.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$4.94 B 2,252.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$3.787 T 1,802,801.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
HK$9.01 B 4,189.22%๐Ÿ‡บ๐Ÿ‡ธ USA